期刊文献+

氨甲环酸对体外循环法洛四联症矫正术患儿的血液保护效应 被引量:3

Blood-saving effect of tranexamic acid in pediatric patients undergoing radical correction of tetralogy of Fallot with cardiopulmonary bypass
原文传递
导出
摘要 目的评价氨甲环酸对体外循环(CPB)法洛四联症矫正术患儿的血液保护效应。方法择期行CPB法洛四联症矫正术患儿56例,性别不限,年龄11个月~14岁,BMI9.8~21.4kg/m^2,ASA分级为Ⅱ或Ⅲ级,左室射血分数〉50%,采用随机数字表法分为2组:氨甲环酸组(TA组,n=30)和生理盐水对照组(NS组,H=26)。TA组切皮前经20min静脉输注氨甲环酸负荷量10mg/kg,继以10mg·kg^-1·h^-1速率维持至术毕,NS组按照同样方法给予等容量生理盐水。记录术后24h引流量、红细胞、新鲜冰冻血浆、血小板和冷沉淀的输入量,记录二次开胸止血情况和TA组术后1周门静脉及肝动脉血栓的发生情况。结果与NS组比较,TA组术后24h引流量、红细胞、新鲜冰冻血浆、血小板及冷沉淀输入量减少(P〈0.05)。TA组无二次开胸止血,NS组二次开胸止率血15%。TA组均未见门静脉及肝动脉血栓。结论氨甲环酸(负荷量10mg/kg,维持量10mg·kg~·h^-1)对CPB法洛四联症矫正术患儿具有血液保护效应,且安全性较高。 Objective To evaluate the blood-saving effect of tranexamic acid in pediatric patients undergoing radical correction of tetralogy of Fallot with cardiopulmonary bypass ( CPB). Methods A total of 56 children of both sexes, aged 11 months-14 yr, with body mass index of 9.8-21.4 kg/m^2, of ASA physical status Ⅱ or Ⅲ, with left ventrieular ejection fraction 〉50%, scheduled for elective radical correction of tetralogy of Fallot with CPB, were randomly divided into 2 groups using a random number table: tranexamic acid group (TA group, n = 30) and normal saline group (NS group, n = 26). Anesthesia was induced with iv midazolam, sufentanil, veeuronium and propofol. The children were endotracheally intubated and mechanically ventilated. Anesthesia was maintained with inhalation of 1%-2% sevoflurane and infusion of propofol, sufentanil and vecuronium. After induction of anesthesia, a loading dose of tranexamic acid 10 mg/kg was intravenously infused over 20 min before skin incision, followed by infusion at a rate of 10 mg·kg^-1·h^-1until the end of surgery in TA group, while the equal volume of normal saline was given instead in NS group. The volume of chest tube drainage at 24 h after surgery and volume of allogeneic red blood cells, fresh frozen plasma, platelet and cryoprecipitate transfused were recorded. The requirement for re-thoracotomy for bleeding, and the incidence of hepatic artery and portal vein thrombosis were also recorded. Results Compared to NS group, the volume of chest tube drainage at 24 h after surgery and volume of allogeneic red blood cells, fresh frozen plasma, platelet and cryoprecipitate transfused were significantly reduced in TA group. No re-thoracotomy was required in TA group, and the rate of re-thoracotomy was 15% in NS group. No hepatic artery and portal vein thrombosis were detected in group TA. Conclusion Tranexamic acid (loading dose 10 mg/kg, maintenance dose 10mg·kg^-1·h^-1) can provide blood-saving effect and has high security in pediatric patients undergoing radical correction of tetralogy of Fallot with CPB.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2015年第6期677-679,共3页 Chinese Journal of Anesthesiology
关键词 氨甲环酸 法洛四联症 心肺转流术 儿童 Tranexamic acid Tetralogy of Fallot Cardiopulmonary bypass Child
  • 相关文献

参考文献7

  • 1张振,王武军,王振康.法洛四联症患者围手术期凝血功能变化及意义[J].中国胸心血管外科临床杂志,2009,16(3):244-245. 被引量:7
  • 2Sarupria A, Makhija N, Lakshmy R, et al. Comparison of dif- ferent doses of e-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety[J].l Cardiothorac Vasc Anesth, 2013,27 ( 1 ) : 23 -29.
  • 3Brown JR, Birkmmeyer N J, O'Connor GT. Meta-analysis com- paring the effective and adverse outcomes of antifibrinolytic agents in cardiac surgery [J]. Circulation, 2007,115 (22) : 2801-2813.
  • 4De Bonis M, Cavaliere F, Alessandrini F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double- blind, prospective, randomized, placebo-controlled study[J].J Thorac Cardiovasc Surg, 2000,119 ( 3 ) : 575-580.
  • 5Dowd NP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass[J].Anesthesiol- ogy,2002,97 (2) :390-399.
  • 6石佳,袁素,薛庆华,王古岩,王越夫,李立环.氨甲环酸对体外循环冠状动脉旁路移植术患者的血液保护作用[J].中华麻醉学杂志,2012,32(12):1460-1462. 被引量:9
  • 7Dunn C J, Goa KL. Tranexamic acid: a review of its use in sur- gery and other indications[J]. Drugs, 1999,57(6) : 1005-1032.

二级参考文献12

  • 1史旭波,胡大一.血栓形成与凝血机制及调节[J].临床荟萃,2007,22(14):989-991. 被引量:22
  • 2Silversides CK, Granton JT, Konen E, et al. Pulmonary thrombosis in adults with eisenmenger syndrome. J Am Coll Cardiol, 2003, 42(11) :1982-1987.
  • 3Goel M, Shome DK, Singh ZN, et al. Haemostatic changes in children with cyanotic and acyanotic congenital heart disease. Indian Heart J, 2000, 52(5) :559-563.
  • 4Auluck A, Manohar C. Haematological considerations in patients with cyanotic congenital heart disease: a review. Dent Update, 2006, 33(10) 1617-618, 620-622.
  • 5Kraaijenhagen RA, in' t Anker PS, Koopman MM, et al. High plasma concentration of factor Ⅷc is a major risk factor for venous thromboembolism. Thromb Haemost, 2000, 83 (1) : 5-9.
  • 6van Hylckama Vlieg A, van der Linden IK, Bertina RM, et al. High levels of factor Ⅸ increase the risk of venous thrombosis. Blood, 2000, 95(12):3678-3682.
  • 7Linden MD. The hemostatic defect of cardiopulmonary bypass[J].Journal of Thrombosis and Thrombolysis,2003,(03):129-147.
  • 8Zacharias A,Habib RH. Factors predisposing to median sternotomy complications.Deep vs superficial infection[J].Chest,1996,(05):1173-1178.
  • 9Fox KA,Mehta SR,Peters R. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the clopidogrel in Unstable angina to prevent Recurrent is chemic Events (CURE) Trial[J].Circulation,2004,(10):1202-1208.
  • 10Dowd NP,Karski JM,Cheng DC. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass[J].Anesthesiology,2002,(02):390-399.

共引文献14

同被引文献31

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部